Yung-Tsai Lee1, Wei-Hsian Yin1,2, Ho-Ping Yu1, Jeng Wei1. 1. Heart Center, Cheng-Hsin General Hospital. 2. Faculty of Medicine, School of Medicine, National Yang Ming University, Taipei, Taiwan.
Abstract
BACKGROUND: Transfemoral (TF) access is associated with lower rates of surgical conversion and mortality compared with non-TF access for transcatheter aortic valve replacement (TAVR). Therefore, efforts should be made to make this procedure even less invasive, allowing more TAVR procedures to be performed through femoral access. We herein describe our single-center experience of using one-stage percutaneous internal endoconduits for TAVR in patients with unfavorable iliac artery anatomy. METHODS: Between March 2013 andMarch 2016, 113 consecutive patients with severe aortic stenosis at high risk for conventional cardiac surgery underwent TAVR at the Cheng Hsin General Hospital. The patients can be divided into Cohort A (March 2013-December 2014) and Cohort B (January 2015-March 2016). RESULTS: In the Cohort A, 6 out of the 53 (11.4%) with unfavorable iliac artery anatomy were treated by trans-subclavian approach (n = 3, 5.7%) or direct aortic approach (n = 3, 5.7%); while in the Cohort B, none (0%) of the 5 patients with unfavorable iliac artery anatomy among 60 consecutive TAVR cases needed non-TF approach (Cohort A vs. Cohort B = 11.4% vs. 0%, p = 0.024) and they were all successfully treated with the use of an internal endoconduit. CONCLUSIONS: The use of internal endoconduits can further increase the number of patients who can be treated through femoral artery access for TAVR and substantially reduce the need of non-TF approaches.
BACKGROUND: Transfemoral (TF) access is associated with lower rates of surgical conversion and mortality compared with non-TF access for transcatheter aortic valve replacement (TAVR). Therefore, efforts should be made to make this procedure even less invasive, allowing more TAVR procedures to be performed through femoral access. We herein describe our single-center experience of using one-stage percutaneous internal endoconduits for TAVR in patients with unfavorable iliac artery anatomy. METHODS: Between March 2013 andMarch 2016, 113 consecutive patients with severe aortic stenosis at high risk for conventional cardiac surgery underwent TAVR at the Cheng Hsin General Hospital. The patients can be divided into Cohort A (March 2013-December 2014) and Cohort B (January 2015-March 2016). RESULTS: In the Cohort A, 6 out of the 53 (11.4%) with unfavorable iliac artery anatomy were treated by trans-subclavian approach (n = 3, 5.7%) or direct aortic approach (n = 3, 5.7%); while in the Cohort B, none (0%) of the 5 patients with unfavorable iliac artery anatomy among 60 consecutive TAVR cases needed non-TF approach (Cohort A vs. Cohort B = 11.4% vs. 0%, p = 0.024) and they were all successfully treated with the use of an internal endoconduit. CONCLUSIONS: The use of internal endoconduits can further increase the number of patients who can be treated through femoral artery access for TAVR and substantially reduce the need of non-TF approaches.
Authors: Anna Sonia Petronio; Marco De Carlo; Cristina Giannini; Francesco De Caro; Uberto Bortolotti Journal: EuroIntervention Date: 2013-09-10 Impact factor: 6.534
Authors: Jeroen J Bax; Victoria Delgado; Vinayak Bapat; Helmut Baumgartner; Jean P Collet; Raimund Erbel; Christian Hamm; Arie P Kappetein; Jonathon Leipsic; Martin B Leon; Philip MacCarthy; Nicolo Piazza; Philippe Pibarot; William C Roberts; Josep Rodés-Cabau; Patrick W Serruys; Martyn Thomas; Alec Vahanian; John Webb; Jose Luis Zamorano; Stephan Windecker Journal: Eur Heart J Date: 2014-07-25 Impact factor: 29.983
Authors: Adam B Greenbaum; Vasilis C Babaliaros; Marcus Y Chen; Annette M Stine; Toby Rogers; William W O'Neill; Gaetano Paone; Vinod H Thourani; Kamran I Muhammad; Robert A Leonardi; Stephen Ramee; James F Troendle; Robert J Lederman Journal: J Am Coll Cardiol Date: 2016-10-29 Impact factor: 24.094
Authors: A Pieter Kappetein; Stuart J Head; Philippe Généreux; Nicolo Piazza; Nicolas M van Mieghem; Eugene H Blackstone; Thomas G Brott; David J Cohen; Donald E Cutlip; Gerrit-Anne van Es; Rebecca T Hahn; Ajay J Kirtane; Mitchell W Krucoff; Susheel Kodali; Michael J Mack; Roxana Mehran; Josep Rodés-Cabau; Pascal Vranckx; John G Webb; Stephan Windecker; Patrick W Serruys; Martin B Leon Journal: Eur Heart J Date: 2012-10 Impact factor: 29.983
Authors: Robert M A van der Boon; Bertrand Marcheix; Didier Tchetche; Alaide Chieffo; Nicolas M Van Mieghem; Nicolas Dumonteil; Olivier Vahdat; Francesco Maisano; Patrick W Serruys; A Pieter Kappetein; Jean Fajadet; Antonio Colombo; Didier Carrié; Ron T van Domburg; Peter P T de Jaegere Journal: Ann Thorac Surg Date: 2013-11-19 Impact factor: 4.330
Authors: Martin B Leon; Craig R Smith; Michael J Mack; Raj R Makkar; Lars G Svensson; Susheel K Kodali; Vinod H Thourani; E Murat Tuzcu; D Craig Miller; Howard C Herrmann; Darshan Doshi; David J Cohen; Augusto D Pichard; Samir Kapadia; Todd Dewey; Vasilis Babaliaros; Wilson Y Szeto; Mathew R Williams; Dean Kereiakes; Alan Zajarias; Kevin L Greason; Brian K Whisenant; Robert W Hodson; Jeffrey W Moses; Alfredo Trento; David L Brown; William F Fearon; Philippe Pibarot; Rebecca T Hahn; Wael A Jaber; William N Anderson; Maria C Alu; John G Webb Journal: N Engl J Med Date: 2016-04-02 Impact factor: 91.245
Authors: Daniel J Blackman; Paul D Baxter; Chris P Gale; Neil E Moat; Philip A Maccarthy; David Hildick-Smith; Uday Trivedi; David Cunningham; Mark A DE Belder; Peter F Ludman Journal: J Interv Cardiol Date: 2013-12-30 Impact factor: 2.279